宮頸疾病病理《生殖系統(tǒng)和乳腺疾病》課件_第1頁
宮頸疾病病理《生殖系統(tǒng)和乳腺疾病》課件_第2頁
宮頸疾病病理《生殖系統(tǒng)和乳腺疾病》課件_第3頁
宮頸疾病病理《生殖系統(tǒng)和乳腺疾病》課件_第4頁
宮頸疾病病理《生殖系統(tǒng)和乳腺疾病》課件_第5頁
已閱讀5頁,還剩173頁未讀 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡介

生殖系統(tǒng)和乳腺疾病

Diseasesofgenitalsystemandmammarygland

Hereisanormalcervixwithasmooth,glisteningmucosalsurface.Thecervicalosissmallandround,typicalforanulliparouswoman.Theoswillhaveafish-mouthshapeafteroneormorepregnancies.Thenormaladultvaginalmucosawithawrinkledappearance.Thecervixhasbeenopenedtorevealanendocervicalcanalleadingtotheloweruterinesegmentattherightthathasanerythematousappearanceextendingtothecervicalosconsistentwithchronicinflammation.Theyellowdashedlinemarkstheouterboundaryofthetransformationzone.Outsidetheboundarythelong-establishedandthickstratifiedsquamousepitheliumappearswhiteorlightpinkfollowingthediluteacidtreatment.Insidetheboundary,thetransformationzoneischaracterizedbyareasofthinepithelium,whichappearredoralmostinflamed.

1.生育期婦女最常見

2.多繼發(fā)于分娩、流產(chǎn)等→子宮頸損傷

3.臨床:白帶過多

一、慢性子宮頸炎(Chroniccervicitis)

常見感染:鏈球菌、腸球菌、大腸桿菌、葡萄球菌等

特殊感染:沙眼衣原體、淋球菌、病毒

(單純皰疹病毒、人乳頭狀瘤病毒、巨細(xì)胞病毒等)、結(jié)核菌、寄生蟲及放線菌等Etiology肉眼:宮頸粘膜充血、腫脹,顆粒狀或糜爛狀Pathologicalchanges

子宮頸粘膜充血水腫間質(zhì)單核C、淋巴C、漿C浸潤子宮頸柱狀上皮、腺上皮增生或鱗狀化生

子宮頸息肉(cervicalpolyp)

有時(shí)子宮頸囊腫

(納博特囊腫,Nabothiancyst)鏡下:Thisisnormalcervicalnon-keratinizingsquamousepithelium.Thesquamouscellsshowmaturationfrombasallayertosurface.Thisischroniccervicitisatthesquamo-columnarjunctionofthecervix.Smallrounddarklymphocytesareseeninthesubmucosa,andthereisalsohemorrhage.Squamousmetaplasiaofcervix

CervicalpolypNabothiancystInthecervix,koilocytoticchangewithhumanpapillomavirus(HPV)infection,withvacuolizationofepithelialcells.

子宮頸糜爛

假性糜爛-柱狀上皮代替鱗狀上皮,多見

真性糜爛-鱗狀上皮壞死脫落

Cervicalerosionoccurswhenthesurfaceofthecervixisreplacedwithinflamedtissuefromthecervicalcanal.Theconditionmaybecausedbytrauma,infectionorchemicals.二、子宮頸上皮非典型增生和原位癌

子宮頸上皮非典型增生-癌前病變異型細(xì)胞增生,從基底層向表層發(fā)展

原位癌上皮全層為異型細(xì)胞所替代,未突破基底膜

好發(fā)部位:子宮頸鱗-柱上皮交界帶

(移行帶)(Cervicalepithelialdysplasiaandcarcinomainsitu)異型細(xì)胞:類似正?;准?xì)胞或體積較小,大小不等,細(xì)胞排列紊亂,可見核分裂。Ⅰ級(輕度)→異型細(xì)胞限于上皮下1/3↓(CINⅠ)多數(shù)可消退Ⅱ級(中度)→異型細(xì)胞累及上皮下2/3↓(CINⅡ)Ⅲ級(重度)→異型細(xì)胞超過上皮2/3以上↓(CINⅢ)原位癌

→上皮全層細(xì)胞異型,極性消失,但基底膜完整↓(CINⅢ)原位癌累及腺體(仍為原位癌)↓浸潤癌→突破基底膜,向上皮下浸潤擴(kuò)展

重度非典型增生和原位癌沒有明顯界限,原位癌的異型細(xì)胞多形性更顯著,核分裂多見。子宮頸上皮內(nèi)瘤變

(Cervicalintraepithelialneoplasia,CIN)2014版WHO分類:宮頸鱗狀上皮前驅(qū)病變細(xì)胞學(xué)與組織學(xué)采用相同的診斷術(shù)語,共同的臨床處理方案低級別鱗狀上皮內(nèi)病變(LSIL)CINI(VaIN1)、扁平濕疣、尖銳濕疣ICD-O:/0觀察隨訪、避免過度治療高級別鱗狀上皮內(nèi)病變(HSIL)CINII-III(VaINII-III)ICD-O:/2手術(shù)治療Cervicalintraepithelialneoplasia(CIN-1and-2)Cervicalintraepithelialneoplasia(CIN-3)Cervicalintraepithelialneoplasia(CIN-3)CervicalcarcinomainsituCervicalcarcinomainsituwithglands

輕度非典型增生:多數(shù)可自然消退

<2%→浸潤癌非典型增生→

原位癌約10年

>20%

CINⅢ

→浸潤癌10年內(nèi)非典型增生+16、18或33型HPV感染→較高惡變傾向檢查手段:碘液實(shí)驗(yàn)、脫落細(xì)胞學(xué)、組織病檢

Prognosis三、子宮頸癌1.女性高發(fā)惡性腫瘤之一,開展普查→晚期癌↓,5年生存率和治愈率↑2.40-60歲高發(fā)3.臨床:陰道不規(guī)則流血、接觸性出血、白帶↑

(Carcinomaofthecervix)

*

與早婚、多產(chǎn)、性生活紊亂、子宮頸裂

傷、包皮垢、感染等因素有關(guān)*通常繼發(fā)于CIN

*與人類乳頭狀瘤病毒(HPV)16、18型,其次

31、33型的感染有關(guān)Etiology組織來源子宮頸陰道部或移行帶:鱗狀上皮子宮頸管粘膜柱狀上皮柱狀上皮下的儲(chǔ)備細(xì)胞大體分型:糜爛型外生菜花型內(nèi)生浸潤型潰瘍型Pathologicalchanges1.子宮頸鱗狀細(xì)胞癌:占90%

早期浸潤癌(微小浸潤型鱗狀細(xì)胞癌)浸潤癌少數(shù)腫瘤細(xì)胞突破基底膜浸潤間質(zhì)的深度不超過基底膜下5mm沒有血管浸潤也無淋巴結(jié)轉(zhuǎn)移常無明顯臨床癥狀癌組織突破基底膜明顯浸潤間質(zhì),深度超過基底膜下5mm伴有臨床癥狀者組織分型高分化鱗癌(20%):

癌巢、角化珠,核分裂不多鏡下:中分化鱗癌

(60%):無明顯角化和癌珠形成,不規(guī)則和條型癌巢,核分裂和細(xì)胞異型性較明顯低分化磷癌(20%):細(xì)胞呈小梭形,似基底細(xì)胞,異型性及核分裂都很明顯,對放射線最敏感,但預(yù)后較差2.子宮頸腺癌:占10-25%

Alargeprotrudingmassisseenincervicalcanalextendingtothefornixofvagina.Adenocarcinomainsitu

Poorlydifferentiatedadenocarcinoma

直接蔓延:膀胱、直腸、盆腔、陰道、宮體淋巴道轉(zhuǎn)移:

最常見,子宮旁→閉孔、髂內(nèi)、髂外、髂總、腹股溝、骶前Ln,晚期鎖骨上Ln

血道轉(zhuǎn)移:肺、胃、肝SpreadingandmetastasisThisisalargercervicalsquamouscellcarcinomawhichspreadtothevagina.Thisisanotherpelvicexenterationforcervicalsquamouscellcarcinoma.Theirregulargrey-browntumorextendstowardbladderandupintotheuterus.Invasivesquamouscarcinomaofcervixinvascularchannel.Thepresenceoftumorcellswithinthelumenofacapillary-likespaceisevidenceforaggressivegrowthpotentialinsquamouscarcinomaofthecervixandhasbeencorrelatedwithincreasedriskforregionallymphnodemetastasis.1.不規(guī)則陰道流血、接觸性出血2.白帶增多3.腰骶部疼痛4.子宮膀胱瘺/子宮直腸瘺5.定期脫落細(xì)胞檢查-早期發(fā)現(xiàn)Clinicalrelations臨床分期:0期:原位癌I期:局限于子宮頸內(nèi)Ⅱ期:侵及盆腔和陰道Ⅲ期:侵及盆腔壁和陰道下1/3Ⅳ期:侵出骨盆,累及膀胱粘膜或直腸四.子宮平滑肌瘤

Leiomyomaoftheuterus1.最常見2.≥30歲,70%3.多無癥狀,出血,尿頻,不孕,自然流產(chǎn),絕經(jīng)后萎縮4.遺傳傾向PathologicalchangesAlarge,solitaryleiomyoma.AsubmucosalleiomyomaMultiplesubmucosal,intramural,andsubserosalleiomyomasoftheuterus.

Reddegeneration生長部位:子宮肌層、子宮漿膜下或子宮內(nèi)膜下單發(fā)或多發(fā):多者達(dá)數(shù)十個(gè)大小懸殊:小者僅鏡下可見,大者>30cm形態(tài):球形或不規(guī)則形,界清,無包膜切面觀:灰白,質(zhì)韌,編織狀或旋渦狀繼發(fā)性改變:玻璃樣變、粘液變、囊性變、鈣化、出血及壞死等大體:與正常子宮平滑肌細(xì)胞相似瘤細(xì)胞-

核排列較密集束狀或編織狀排列核長桿狀,兩端鈍圓,染色質(zhì)纖細(xì)

鏡下:Uterineleiomyomaisabenignconnectivetissuetumorofthesmoothmusclecellsofthemyometrium.Tumorcellsresemblenormalcells(elongated,spindle-shaped,withacigar-shapednucleus)andformbundleswithdifferentdirections(whirled).Thetumoriswellcircumscribed,butnotencapsulated.

良、惡性之間的區(qū)別取決于三個(gè)標(biāo)準(zhǔn):

分裂像

細(xì)胞異型性壞死腫瘤核分裂像10個(gè)/10HP,有細(xì)胞異型性及壞死者為惡性

子宮平滑肌肉瘤

(Leiomyosarcoma)Thisisaleiomyosarcomaprotrudingfrommyometriumintotheendometrialcavityofthisuterus.Muchmorecellularandthecellshavemuchmorepleomorphismandhyperchromatismthanthebenignleiomyoma.Anirregularmitosisisseeninthecenter.子宮體癌(子宮內(nèi)膜腺癌)

(Endometrialadenocarcinoma)1.發(fā)病率上升2.絕經(jīng)期、絕經(jīng)后婦女,50-59歲3不規(guī)則陰道流血4.生長緩慢,轉(zhuǎn)移較晚5.一般與雌激素長期作用有關(guān)肉眼:局部型:多見,多位于子宮底或子宮角,息肉狀、乳頭狀彌漫型:內(nèi)膜彌漫性增厚,灰白質(zhì)脆,伴出血、壞死、潰瘍Pathologicalchanges

鏡下:高分化:多見,腺管排列擁擠、紊亂,輕度異型,似增生的內(nèi)膜腺體中分化:腺體不規(guī)則,排列紊亂,乳頭或篩狀,異型明顯,核分裂易見低分化:實(shí)體片狀,無腺樣結(jié)構(gòu),異型明顯,核分裂多見Theendometrialadenocarcinomainthepolypattheleftismoderatelydifferentiated,asaglandularstructurecanstillbediscerned.Notethehyperchromatismandpleomorphismofthecells,comparedtotheunderlyingendometriumwithcysticatrophyattheright.

Adenocarcinoma,endometrium,uterus,welldifferentiated.Thetallcolumnarepitheliumandwell-definedglandformationillustrateawell-differentiatedadenocarcinoma.Thisisendometrialadenocarcinomawhichcanbeseeninvadingintothesmoothmusclebundlesofthemyometrialwalloftheuterus.Welldifferentiatedadenocarcinomahasinvadedthroughthemusclebundlesofthemyometrium(redarrow).Theadenocarcinomaisindicatedbytheredarrows.

腺棘皮癌:分化較好的腺癌中有良性化生的鱗狀上皮腺鱗癌:腺癌組織中混雜鱗癌上皮直接蔓延:

上-子宮角,輸卵管、卵巢下-宮頸管和陰道外-漿膜、腹膜和大網(wǎng)膜淋巴道:

宮底-腹主動(dòng)脈旁Ln

子宮角-腹股溝Ln

宮頸-宮旁、髂內(nèi)外、髂總Ln血道:肺、肝、骨骼Spreadingandmetastasis臨床分期:Ⅰ期:局限于宮體,5年生存率90%Ⅱ期:累及子宮體和子宮頸,30-50%Ⅲ期:侵入盆腔Ⅳ期:侵出盆腔,累及膀胱和直腸

張三,女,58歲,五年前絕經(jīng),近一月來出現(xiàn)陰道不規(guī)則流血,B超發(fā)現(xiàn)子宮底部見一菜花狀腫物,病理活檢見灰白色質(zhì)脆組織,顯微鏡下腺體排列擁擠、紊亂,細(xì)胞有明顯異型性。病理診斷:?

Casediscuss子宮內(nèi)膜腺癌

乳腺癌

Carcinomaofbreast

Anormalductcells

Bbasementmembrane

Clumen(centerofduct)導(dǎo)管雙層上皮內(nèi)腺上皮,外肌上皮Normallobuleofmammarygland全球每年120萬婦女患乳腺癌,50萬死于該病北美、北歐高我國↑3%/年,“第一癌癥殺手”40-60歲女性,男性罕見1%乳腺外上象限>中央?yún)^(qū)>內(nèi)上象限

來自乳腺終末導(dǎo)管小葉單元上皮IntroductionER、PR(+):內(nèi)分泌治療好,預(yù)后好C-erbB-2(+),ER(-):預(yù)后差乳腺是女性激素的靶器官正常乳腺上皮細(xì)胞存在雌激素受體(ER)

孕激素受體(PR)ER、PR→啟動(dòng)細(xì)胞分裂→促乳癌生長Thecellsofthisbreastcarcinomaarehighlypositiveforestrogenreceptorwiththisimmunoperoxidasestain.Estrogenreceptorpositivitycorrelateswithabetterprognosis.Thisisprogesteronereceptor(PR)positivityinabreastcarcinoma.Theusefulnessofthisdeterminationisnotaswellestablishedasforestrogenreceptors.CarcinomasthatarePRpositive,butnotERpositive,mayhaveaworseprognosis.分類:乳腺癌非浸潤性癌

浸潤性癌導(dǎo)管內(nèi)原位癌小葉原位癌粉刺癌非粉刺導(dǎo)管內(nèi)癌Paget病浸潤性導(dǎo)管癌浸潤性小葉癌特殊類型癌小管癌典型髓樣癌粘液癌

屬于原位癌

沒有突破導(dǎo)管和腺泡的基底膜分類:導(dǎo)管內(nèi)原位癌

小葉原位癌

一、非浸潤性癌1.導(dǎo)管內(nèi)原位癌

(Intraductalcarcinomainsitu)

起于乳腺小葉的終末導(dǎo)管限于導(dǎo)管內(nèi),基膜完整檢出率↑,5%-15%-30%

組織學(xué):粉刺型,非粉刺型

20年,30%-浸潤癌AnormalductcellsBductalcancercellsCbasementmembraneDlumen(centerofduct)Intraductalcarcinoma.Theneoplasticcellsareconfinedtotheductbythebasementmembrane.Theneoplasticcellsaremonotonouswithroundtoovalnucleiandlittlepleomorphism.Thecellbordersarewelldemarcated.

(1)粉刺癌(Comedocarcinoma)

>50%位于乳腺中央部質(zhì)硬、腫塊明顯,易觸診查出導(dǎo)管擴(kuò)張,內(nèi)含壞死物質(zhì)擠壓導(dǎo)管,壞死物質(zhì)會(huì)像粉刺一樣被擠出

鏡下:實(shí)性排列,中央壞死-特征癌細(xì)胞大,嗜酸,大小不一,核仁明顯,病理性核分裂多壞死區(qū)常見鈣化導(dǎo)管周間質(zhì)纖維組織↑,慢性炎C浸潤C(jī)omedocarcinomaischaracterizedbythepresenceofrapidlyproliferating,high-grademalignantcells.Thecellsinthecenteroftheductsareoftennecroticandcalcify.Thiscentralnecrosisleadstothegrosscharacteristicofextrusionofcheesymaterialfromtheductswithpressure.

ComedocarcinomaNotecentralnecrosis(*)andpleomorphicnuclei.Thecellsdonotextendbeyondthebasementmembrane(arrow).Thecenteroftheductcontainscalcifiedmaterialsurroundedbynecrotic,mostlyacellular

debris.Theneoplasticcellsexhibitnuclearpleomorphismandhyperchromasia.Thebasementmembraneisintact(2)非粉刺型導(dǎo)管內(nèi)癌(Noncomedointraductalcarcinoma)實(shí)性、乳頭狀、篩狀排列,輕微壞死癌細(xì)胞小,較規(guī)則導(dǎo)管周間質(zhì)纖維組織增生較輕2.小葉原位癌(Lobularcarcinomainsitu)

來自小葉的終末導(dǎo)管及腺泡

癌細(xì)胞局限于管泡內(nèi),未穿破其基底膜,小葉結(jié)構(gòu)存在

多中心性,常累及雙側(cè),無明顯腫塊癌細(xì)胞實(shí)性排列,小而一致,核圓,核分裂罕見癌細(xì)胞無壞死,無間質(zhì)的炎癥反應(yīng)、纖維組織增生

AnormallobularcellsBlobularcancercellsCbasementmembraneLobularcarcinomainsituconsistsofaneoplasticproliferationofcellsintheterminalbreastductsandacini.Thecellsaresmallandround.Thereisa30%riskfordevelopmentofinvasivecarcinomainthesameortheoppositebreast.導(dǎo)管內(nèi)癌--乳頭、乳暈乳頭、乳暈可見滲出、淺表潰瘍又稱“濕疹樣癌”表皮內(nèi):瘤細(xì)胞孤立散在、成簇分布

大而異型,胞質(zhì)透明3.佩吉特病(Pagetdisease)癌細(xì)胞穿破乳腺導(dǎo)管或腺泡的基底膜而侵入間質(zhì)占乳腺癌>85%分類:浸潤性導(dǎo)管癌和浸潤性小葉癌兩種類型可并存,占10%,浸潤性小葉癌的預(yù)后較差

二、浸潤性癌導(dǎo)管內(nèi)癌細(xì)胞突破管壁基底膜向間質(zhì)浸潤最常見(70%)1.浸潤性導(dǎo)管癌(Invasiveductalcarcinoma)

AnormalductcellsBductalcancercellsbreakingthroughthebasementmembraneCbasementmembrane大體:色灰白,質(zhì)硬,無包膜界不清,活動(dòng)度差侵潤性生長乳頭下陷,橘皮樣外觀PathologicalchangesHereisaclassicinfiltratingductalcarcinomaThisinfiltratingductalcarcinomaofthebreastisdefinitelyinfiltratingthesurroundingbreast.Thecentralwhiteareaisveryhardandgritty,becausetheneoplasmisproducingadesmoplasticreactionwithlotsofcollagen.Thisisoftencalleda"scirrhous"appearance.鏡下:巢狀、團(tuán)索狀、腺樣,可見導(dǎo)管內(nèi)原位癌癌細(xì)胞異型明顯,核分裂多伴壞死、纖維組織增生單純癌、硬癌、不典型髓樣癌Cordsandnestsofcellsirregularlyinvadethetissue.Reactivefiborsis(thedesmoplasticreaction)surroundstumorcells(arrows).Inthecenterisaductlinedbycarcinomacells.However,thisductalcarcinomaisnotconfinedtojusttheduct,butinfiltratesoutwardintothesurroundingstromaasaninfiltratingductalcarcinomaThepleomorphismofthecarcinomacellswithintheductinthecenter(inacribriformpattern),aswellastheneoplasticcellsinfiltratingthroughthestromaandfat,canbeseenwiththisinfiltratingductalcarcinoma.Theinfiltratingductalcarcinomaofbreasthaspleomorphiccellsinfiltratingthroughthestroma.Thebluearrowssurroundanestofneoplasticcellsinaninfiltratingductalcarcinoma.Thegreenarrowheadspointtointerveningstroma.Mitoticfiguresareseen.Small,duct-likestructuresareseeninvadingthebreaststroma.Sometumorcellsaresingle.Notetheabundantcollagenousstroma,characteristicofbreastcarcinomas.Scirrhouscarcinomaofthebreast

5%~10%,老年婦女多見癌細(xì)胞突破基底膜向間質(zhì)浸潤約20%可累及雙側(cè)乳房,彌漫性多灶性分布,不易發(fā)現(xiàn)2.浸潤性小葉癌(Invasivelobularcarcinoma)AnormalcellsBlobularcancercellsbreakingthroughthebasementmembraneCbasementmembrane

*橡皮樣,灰白柔韌,邊界不清*

轉(zhuǎn)移特殊性:腦脊液、漿膜面、卵巢、子宮、骨髓肉眼:

串珠狀、細(xì)條索或環(huán)形排列正常導(dǎo)管周圍癌細(xì)胞小、大小一致、核分裂象少見鏡下:Thisisacloserviewoflineararraysoflobularcarcinomacellsinfiltratingthroughdensefibrousstroma.InvasivelobularcarcinomaTheneoplastic

cellsarenotableforeccentricnucleisetintomucinrichcytoplasm.Thenucleiarehyperchromaticandroundtooval.Nopleomorphismormitosesareseen.Thestromaisverydensewithaccellularcollagen.Singlestrandsofmalignantcellsinfiltratingthestroma(Indianfiling).3.特殊型癌

具有特殊形態(tài),如粘液癌、大汗腺樣癌、腺樣囊性癌、鱗狀細(xì)胞癌、炎性癌

直接浸潤:乳腺實(shí)質(zhì)、乳頭、皮膚、筋膜、胸肌及胸壁

淋巴結(jié)轉(zhuǎn)移:

外上、外下象限和中心區(qū)→同側(cè)腋窩淋巴結(jié)

內(nèi)上、內(nèi)下象限→乳內(nèi)動(dòng)脈旁淋巴結(jié)

血行轉(zhuǎn)移:遠(yuǎn)處任何器官

轉(zhuǎn)移途徑135影響預(yù)后的因素

早期不易發(fā)現(xiàn),發(fā)現(xiàn)時(shí)約50%病例已有局部淋巴結(jié)轉(zhuǎn)移

原發(fā)灶大小:<1cm、無LN轉(zhuǎn)移者預(yù)后好

淋巴結(jié)轉(zhuǎn)移:無LV轉(zhuǎn)移者5年生存率70-80%

組織學(xué)類型:

組織學(xué)分級:腺管的分化程度、細(xì)胞異型性、核分裂

ER和PR:內(nèi)分泌治療、預(yù)后

HER-2:靶向藥物Herceptin、預(yù)后

DNA倍體數(shù):

新輔助化療:乳腺癌的分子分型Nature

2000;406,

747–752乳腺癌Her-2靶向治療乳腺纖維腺瘤Fibroadenomaofbreast

最常見的良性腫瘤20-30歲多見單個(gè)或多個(gè),單側(cè)或雙側(cè)發(fā)生界清,切片灰白、質(zhì)韌、可見裂隙狀,粘液

樣外觀乳腺增生性病變Proliferativelesionsofbreast

乳腺纖維囊性變Fibrocysticchangesofbreast硬化性腺病Sclerosingadenosis乳腺纖維囊性變一組非腫瘤性病變,以末梢導(dǎo)管、腺泡擴(kuò)張,間質(zhì)纖維組織和上皮不同程度增生為特點(diǎn)25-45

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論